Tropical Nutmeg (Myristica fragrans)
Myristica fragrans, commonly called nutmeg, contains bioactive compounds including myristicin, elemicin, and safrole that drive its antimicrobial and anti-inflammatory properties. These lignan and phenylpropanoid compounds inhibit microbial replication and modulate cytokine signaling pathways, making it a subject of growing pharmacological interest.

Origin & History
Tropical nutmeg is the dried seed of Myristica fragrans Houtt., an evergreen tree native to Indonesia's Maluku Islands, now cultivated in India, Sri Lanka, and the Caribbean. The seed is processed through drying and grinding into powder, or extracted using methanol, steam distillation for essential oil, or solvent extraction to obtain bioactive compounds including lignans, terpenoids, and phenolic compounds.
Historical & Cultural Context
Myristica fragrans seed has been used for centuries in Traditional Chinese Medicine, Ayurveda, and Unani systems for gastrointestinal regulation, including diarrhea and digestion support, as a tonic, and for pain relief. Historical applications as antimicrobial, anti-inflammatory, and neuroprotective agent bridge to modern preclinical confirmations of hypolipidemic, antioxidant, and antidiabetic effects.
Health Benefits
• Antiparasitic activity: Mouse study showed 80-81% reduction in Cryptosporidium parvum oocyst shedding at 500 mg/kg (preliminary evidence) • Anti-inflammatory effects: Reduces cytokines (IFN-γ, IL-4) and IgG levels in infection models (preliminary evidence) • Antifungal properties: Isolated elemicin showed activity against Candida tropicalis and Aspergillus flavus (in-vitro evidence) • Potential anticancer activity: Myristicin demonstrated cytotoxicity against human rhabdomyosarcoma cells (in-vitro evidence) • Antioxidant and hypoglycemic effects: Demonstrated in preclinical models through lignan and terpenoid activity (preliminary evidence)
How It Works
Myristicin, a phenylpropanoid in Myristica fragrans, inhibits monoamine oxidase (MAO) and modulates NF-κB signaling to suppress pro-inflammatory cytokine production including IFN-γ and IL-4. Elemicin demonstrates antifungal activity by disrupting fungal cell membrane integrity through inhibition of ergosterol biosynthesis. Safrole and its derivatives interfere with parasitic oocyst wall formation in Cryptosporidium parvum, contributing to the observed 80–81% reduction in oocyst shedding at 500 mg/kg doses in mouse models.
Scientific Research
Current evidence is limited to preclinical studies with no human clinical trials, RCTs, or meta-analyses identified. The most substantial study (PMID: 39507782) tested methanolic seed extract in immunocompetent (n=50) and immunosuppressed mice (n=50), showing 80-81% parasite reduction comparable to nitazoxanide. Additional in-vitro studies demonstrated antifungal and cytotoxic effects of isolated compounds.
Clinical Summary
Current evidence for Myristica fragrans is predominantly preclinical, derived from in vitro assays and rodent models rather than human clinical trials. A mouse study demonstrated an 80–81% reduction in Cryptosporidium parvum oocyst shedding at 500 mg/kg, representing a notable antiparasitic signal but not directly translatable to human dosing. Anti-inflammatory outcomes, specifically reductions in IFN-γ, IL-4, and IgG levels, have been observed in infection-model animal studies, with no randomized controlled trials in humans confirming these effects. The antifungal properties of isolated elemicin show promise in vitro, but clinical efficacy and optimal dosing in humans remain unestablished.
Nutritional Profile
Tropical Nutmeg (Myristica fragrans) seed (per 100g dried, ground): Macronutrients: Calories ~525 kcal, Total fat ~36g (saturated fat ~25g, primarily myristic acid/tetradecanoic acid 60-80% of fatty acid composition), Carbohydrates ~49g (dietary fiber ~21g, net carbs ~28g), Protein ~6g. Key Micronutrients: Manganese ~2.9mg (145% DV) - one of the richest dietary sources; Copper ~1.0mg (~111% DV); Magnesium ~183mg (~46% DV); Phosphorus ~213mg (~21% DV); Zinc ~2.2mg (~20% DV); Iron ~3.0mg (~17% DV); Calcium ~184mg (~18% DV); Potassium ~350mg (~10% DV); Thiamine (B1) ~0.35mg (~29% DV); Folate ~76µg (~19% DV); Vitamin B6 ~0.16mg (~12% DV). Bioactive Compounds: Essential oil fraction (5-15% of dry weight) dominated by monoterpenes - sabinene (20-50% of volatile fraction), α-pinene (15-30%), β-pinene (5-15%), limonene (2-8%), myrcene (1-5%). Phenylpropanoids: myristicin (1-4% of essential oil, primary psychoactive constituent at high doses), elemicin (0.1-2%), safrole (trace to 0.5%), eugenol (0.5-2%). Fixed oils (nutmeg butter, ~24-40g/100g): trimyristin comprising ~75% of fixed oil fraction. Lignans: erythro- and threo-dihydroguaiaretic acid present at ~0.1-0.5% dry weight. Flavonoids: phenolic compounds including malabaricone A, B, C (~0.1-0.3%). Bioavailability Notes: Fat-soluble compounds (myristicin, elemicin, myristic acid) require dietary fat for absorption; myristic acid, while highly saturated, demonstrates moderate intestinal absorption (~95%); myristicin undergoes hepatic first-pass metabolism to amphetamine-like metabolites at toxic doses (>5g whole seed); manganese bioavailability estimated at 5-10% due to presence of phytates and fiber; essential oil bioavailability enhanced when consumed with lipid-containing foods. Typical culinary serving (~1-2g ground) provides negligible micronutrient contribution but meaningful essential oil exposure (~10-40mg myristicin).
Preparation & Dosage
No human clinical dosages established. Preclinical mouse studies used methanolic seed extract at 500 mg/kg orally. Traditional culinary use involves seed powder but therapeutic doses are not evidenced. No standardization details for myristicin content are available. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Nitazoxanide, Black pepper extract, Turmeric, Ginger, Clove
Safety & Interactions
At culinary doses, Myristica fragrans is generally recognized as safe, but at higher doses (approaching 5–15 g of ground nutmeg), myristicin and elemicin can cause hallucinations, tachycardia, nausea, and anticholinergic symptoms due to MAO inhibition and central nervous system stimulation. Individuals taking MAO inhibitor (MAOI) antidepressants such as phenelzine or tranylcypromine should avoid concentrated nutmeg supplements due to risk of serotonergic or hypertensive crisis. Nutmeg may potentiate the effects of anticoagulants and CNS-active drugs; concurrent use with warfarin or psychoactive medications warrants medical supervision. Pregnant women should avoid supplemental doses of Myristica fragrans, as myristicin and safrole have shown embryotoxic and genotoxic potential in animal studies.